PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Estradiol - Transgender Health - Children & Young People

PAD Profile : Estradiol - Transgender Health - Children & Young People

Keywords :
gender reassignment, gender re-assignment, gender identity clinics, GICs, gender incongruence, sex change, transgender, hormonal therapy, feminisation, transsexuals, hormonal treatment, oestrogens, feminising hormones, oestradiol, gender dysphoria
Brand Names Include :
Elleste Solo MX, Estraderm MX, Estradot, Evorel, FemSeven, Progynova TS, Bedol, Climival, Zumenon

Traffic Light Status

Status 1 of 1.

Status :
Amber
Formulations :
  • Patches
  • Tablets
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
Un
Comments :
No comments returned.
Documents :

Guidelines

The following guidelines are available for this indication.

Other Drugs

Other Indications

Additional Documents

Committee Recommendations

Date
Committee Name
Narrative
05 June 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

With the publication of the final Cass Report and new NHSE commissioning policies, the APC has agreed an AMBER status for gender affirming hormones in children and young people.  This applies to recommendations from both NHS and private providers subject to appropriate shared care protocols being in place.

The following guidance has also been updated:

  • Primary care prescribing guidance, for people who access Gender Identity Services.
  • NHSE guidance on prescribing and dispensing restrictions for puberty blockers and gender affirming hormones
06 December 2023
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

In December 2023, a guide to support primary care prescribing for people who access gender identity services was agreed by the APC. 

The guide includes information on children and young people, requests to prescribe, shared care, on-going care and private providers.

Associated BNF Codes

06. Endocrine System
06.04.01. Female sex hormones and their modulators
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More